LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard

The U.S. Department of Health and Human Services, through the National Cancer Institute's Center for Cancer Research, is seeking to acquire a new Odyssey M Chemi/Fluor Imaging Bundle Standard to replace an outdated protein imaging system used in their laboratory. This state-of-the-art imaging system is essential for supporting ongoing and future intramural research projects by enabling a variety of protein and nucleic acid analyses. The Odyssey M offers simplified workflows and laboratory-wide sharing capabilities, accommodating diverse applications such as fluorescent and colorimetric Western blots, immunocytochemistry, ELISAs, array analyses, high-resolution tissue section imaging, and non-isotopic electrophoretic mobility shift assays. The contract opportunity, posted on May 21, 2026, invites responses by May 27, 2026, and is managed by the Asa Office of the Assistant Secretary for Administration under HHS in Washington, D.C., with the primary performance location in Bethesda, Maryland. Points of contact for this solicitation include Shayna Simpson and Rashiid Cummins, providing direct communication channels for interested vendors. This procurement aims to enhance the lab's research capabilities by installing advanced imaging technology critical to a broad spectrum of cancer research methodologies.